Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Small Pharma Inc V.DMT

Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of depression. It has a portfolio of clinical-stage dimethyltryptamine (DMT)-based assets, SPL026 and SPL028. It has a pipeline of proprietary preclinical assets. Its clinical-stage program, SPL026, a first-generation DMT molecule, has shown proof-of-concept for the potential treatment of MDD. In a Phase IIa study, IV SPL026 demonstrated a rapid and durable antidepressant effect, as well as a favorable safety and tolerability profile. Small Pharma is also advancing SPL028, a second-generation injectable deuterated DMT molecule, in a Phase I trial.


TSXV:DMT - Post by User

Post by GillRipperon Sep 01, 2022 4:18pm
54 Views
Post# 34936492

Eight loading the boat

Eight loading the boatAugust 1 to Sept 1

Kind Regards To All

Gilly

House Positions for C:DMT from 20220801 to 20220901
House Bought $Val Ave Sold $Val Ave Net $Net
8 Eight 961,500 270,982 0.282 0   961,500 -270,982
13 Instinet 1,246,948 268,080 0.215 780,923 139,116 0.178 466,025 -128,964
150 IACP 272,000 57,349 0.211 0   272,000 -57,349
7 TD Sec 453,797 101,385 0.223 199,807 38,882 0.195 253,990 -62,503
57 Interactive 130,788 14,419 0.11 0   130,788 -14,419
39 Merrill Lynch 127,348 23,570 0.185 10,620 2,794 0.263 116,728 -20,776
89 Raymond James 99,760 11,643 0.117 290 71 0.245 99,470 -11,572
80 National Bank 456,558 74,690 0.164 416,125 83,717 0.201 40,433 9,027
83 Mackie 25,000 3,875 0.155 217 59 0.272 24,783 -3,816
124 Questrade 55,361 13,832 0.25 33,400 6,416 0.192 21,961 -7,416
53 Morgan Stanley 122,024 15,592 0.128 102,029 17,932 0.176 19,995 2,340
85 Scotia 99,051 17,077 0.172 88,062 16,971 0.193 10,989 -106
22 Fidelity 3,500 822 0.235 0   3,500 -822
84 ITG84 583 120 0.206 1,388 330 0.238 -805 210
88 Credential 4,000 520 0.13 15,000 3,075 0.205 -11,000 2,555
28 CI 4,000 480 0.12 19,000 2,320 0.122 -15,000 1,840
90 Barclays 3,890 1,038 0.267 20,500 5,867 0.286 -16,610 4,829
79 CIBC 748,758 148,504 0.198 799,455 192,701 0.241 -50,697 44,197
14 Virtu ITG 145,148 24,303 0.167 199,211 41,575 0.209 -54,063 17,272
9 BMO Nesbitt 16,665 4,324 0.259 81,000 15,837 0.196 -64,335 11,513
62 Haywood 98,397 29,027 0.295 197,695 51,661 0.261 -99,298 22,634
19 Desjardins 74,566 18,017 0.242 382,768 50,469 0.132 -308,202 32,452
33 Canaccord 46,250 9,896 0.214 450,233 126,241 0.28 -403,983 116,345
2 RBC 440,112 101,097 0.23 971,850 223,032 0.229 -531,738 121,935
1 Anonymous 1,699,821 378,623 0.223 2,566,252 570,218 0.222 -866,431 191,595
TOTAL 7,335,825 1,589,265 0.217 7,335,825 1,589,284 0.217 0 19


<< Previous
Bullboard Posts
Next >>